4.950USDMkt Cap: 6.17M USDP/E: 0.00Last update: 2026-05-22
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap6.17M USD
Enterprise Value-3.82M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-25.97M USD
Revenue/Share—
Last Price4.950 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees33
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS03835L2079
Valuation
P/E (Trailing)0.00
P/E (Forward)-0.23
PEG—
EV/EBITDA0.14
EV/Revenue—
P/S—
P/B0.52
EPS (TTM)1488.13
EPS (Forward)-21.46
52W Range
4.79038% of range5.210
52W High5.210 USD
52W Low4.790 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-149.40%
ROA-95.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.59M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-289.78%
Net Debt-10.10M USD
Net Debt/EBITDA0.38
Balance Sheet
Debt/Equity0.27
Current Ratio3.36
Quick Ratio3.05
Book Value/Sh9.646 USD
Cash/Share11.66 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 27, 2020
Splits
Last Split1:18
Split DateDec 30, 2025
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)21.00 USD
Target Range21.00 USD – 21.00 USD
# Analysts1
Ownership
Shares Out.1.25M
Float1.25M
Insiders0.06%
Institutions4.47%
Short Interest
Short Ratio2.8d
Short % Float7.81%
Short % Out.7.80%
Shares Short92.20K
Short (prev mo.)133.10K
Technical
SMA 504.718 (+4.9%)
SMA 20016.76 (-70.5%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)26.10K
Avg Vol (10d)18.47K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—